Hygeia Healthcare Holdings Co., Limited repurchased 303,800 ordinary shares on 22 September 2026 via the Hong Kong Stock Exchange, spending HK$2.999 million at prices ranging from HK$9.845 to HK$9.880 per share. The volume-weighted average price for the transaction was HK$9.8721 per share.

Following the buyback, issued shares outstanding (excluding treasury shares) fell 0.0503% to 603.34 million, while treasury shares increased to 15.16 million. The company’s total issued share count remains unchanged at 618.50 million.

The repurchase was executed under the mandate approved on 26 June 2026, which permits the company to buy back up to 60.77 million shares. Cumulative repurchases under this mandate now total 4.40 million shares, equivalent to 0.72% of the issued shares on the mandate date. A 30-day moratorium on new share issues or treasury share disposals is in effect until 22 October 2026.